Search results for "Hep"

showing 10 items of 12243 documents

Evaluation of the animal-assisted therapy in Alzheimer's disease

2017

Animal-assisted therapy sessions have been set up in a protected unit for patients with a dementia-related syndrome. The aim is to measure the effects of animal-assisted therapy on behavioural disorders in daily life and care. The results obtained provided some interesting areas to explore and recommendations with a view to optimising the implementation of such a system.

troubles cognitifstherapymédiation animale[SHS.SOCIO]Humanities and Social Sciences/Sociology[SDV.MHEP.GEG] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontology[SHS.SOCIO] Humanities and Social Sciences/Sociology[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontology[SHS.PHIL]Humanities and Social Sciences/PhilosophyGeneral MedicineAlzheimer's disease030227 psychiatrynursing home03 medical and health sciences0302 clinical medicineanimal-assisted therapycognitive disordersétablissement d’hébergement pour personnes âgées dépendantes[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC][SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]maladie d’AlzheimerComputingMilieux_MISCELLANEOUS030217 neurology & neurosurgerythérapieSoins Gérontologie
researchProduct

Dipeptidyl Enoates As Potent Rhodesain Inhibitors That Display a Dual Mode of Action

2015

Dipeptidyl enoates were prepared through a high-yielding two-step synthetic route. They have a dipeptidic structure with a 4-oxoenoate moiety as a warhead with multiple reactive sites. Dipeptidyl enoates were screened against rhodesain and human cathepsins B and L, and were found to be potent and selective inhibitors of rhodesain. Among them (S,E)-ethyl 5-((S)-2-{[(benzyloxy)carbonyl]amino}-3-phenylpropanamido)-7-methyl-4-oxooct-2-enoate (6) was the most potent, with an IC50 value of 16.4 nm and kinact/Ki=1.6×106 m−1 s−1 against rhodesain. These dipeptidyl enoates display a reversible mode of inhibition at very low concentrations and an irreversible mode at higher concentrations. Inhibition…

trypanosomiasisStereochemistrysleeping sicknessCathepsin LDrug Evaluation PreclinicalChemistry Techniques SyntheticInhibition kineticsCysteine Proteinase InhibitorsBiochemistryCathepsin BInhibitory Concentration 50Structure-Activity RelationshipinhibitorsDrug DiscoveryHumansMoietyMolecular Targeted TherapyGeneral Pharmacology Toxicology and PharmaceuticsIC50Volume concentrationrhodesainPharmacologyChemistryOrganic ChemistryDual modeDipeptidesTrypanocidal AgentsCombinatorial chemistryMolecular Docking SimulationCysteine EndopeptidasesKineticsdipeptidyl enoatesTrypanosomiasis AfricanDocking (molecular)Molecular MedicineCysteine thiolateChemMedChem
researchProduct

El impacto de la inmunosupresión precoz en las complicaciones no asociadas al injerto hepático

2018

La falta de mejora a largo plazo de los resultados post-TH se debe en gran medida a complicaciones no asociadas al injerto en principio muy relacionadas con la exposición crónica a IS. En diferentes estudios se ha demostrado como la minimización de los ICN tiene un efecto protector en términos de toxicidad renal, metabólica, cardíaca y oncogénica. Sin embargo, no existe una evidencia sólida sobre el impacto que pueda tener la IS precoz, es decir aquella administrada en el post-trasplante inicial, y el desarrollo de dichas complicaciones. El grupo de Rodríguez-Perálvarez ha demostrado que tanto los niveles de Tac mayores de 10 ng/mL durante los primeros 15 días post-TH como la presencia de p…

tumores de novoinsuficiencia renalresultados a largo plazotrasplante hepáticoeventos cardiovascularesUNESCO::CIENCIAS MÉDICASmortalidadinmunosupresión:CIENCIAS MÉDICAS [UNESCO]recurrencia carcinoma hepatocelular
researchProduct

Two-particle transverse momentum correlations in pp and p-Pb collisions at energies available at the CERN Large Hadron Collider

2023

Two-particle transverse momentum differential correlators, recently measured in Pb--Pb collisions at energies available at the CERN Large Hadron Collider (LHC), provide an additional tool to gain insights into particle production mechanisms and infer transport properties, such as the ratio of shear viscosity to entropy density, of the medium created in Pb-Pb collisions. The longitudinal long-range correlations and the large azimuthal anisotropy measured at low transverse momenta in small collision systems, namely pp and p-Pb, at LHC energies resemble manifestations of collective behaviour. This suggests that locally equilibrated matter may be produced in these small collision systems, simil…

two particle correlations large hadron colliderCERN Lablongitudinallarge hadron colliderheavy ion scatteringcollectiveFOS: Physical sciencesanisotropy measuredtransverse momentum correlation[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]High Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)transport theoryTeVcorrelation functionNuclear Experiment (nucl-ex)Nuclear ExperimentMonte Carloeffect viscositycorrelation long-rangetwo-particleentropy densityparticle multiplicityCERN LHC Collangular distribution anisotropybroadeningtransverse momentum lowydinfysiikkatwo particle correlations
researchProduct

Työn ja perheen yhteensovittamisen ongelma vanhemmuuden ja yritysorganisaation näkökulmasta

2005

työaikatasa-arvokotityöperheperhepolitiikkajoustottyöelämätyöarkielämä
researchProduct

Search for photons with energies above 1018 eV using the hybrid detector of the Pierre Auger Observatory

2017

A search for ultra-high energy photons with energies above 1 EeV is performed using nine years of data collected by the Pierre Auger Observatory in hybrid operation mode. An unprecedented separation power between photon and hadron primaries is achieved by combining measurements of the longitudinal air-shower development with the particle content at ground measured by the fluorescence and surface detectors, respectively. Only three photon candidates at energies 1-2 EeV are found, which is compatible with the expected hadron-induced background. Upper limits on the integral flux of ultra-high energy photons of 0.027, 0.009, 0.008, 0.008 and 0.007 km-2 sr-1 yr-1 are derived at 95% C.L. for ener…

ultra high energy cosmic rays cosmic ray experimentsPhoton[ PHYS.ASTR ] Physics [physics]/Astrophysics [astro-ph]AstronomyHadronFluxultra high energy cosmic rays; cosmic ray experiments7. Clean energy01 natural sciencesHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)energy: thresholdCosmic ray experiments[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]010303 astronomy & astrophysicsHigh Energy Astrophysical Phenomena (astro-ph.HE)Physicsphoton: productionconstraint: energyCOSMIC-RAYSAugerobservatoryContent (measure theory)ComputingMethodologies_DOCUMENTANDTEXTPROCESSINGFísica nuclearfluorescenceAstrophysics - High Energy Astrophysical PhenomenalongitudinalAstrophysics::High Energy Astrophysical PhenomenaDark matterFOS: Physical sciencesCosmic rayultra high energy cosmic raysdark matterUltra high energy cosmic rays Cosmic ray experiments Astronomy and Astrophysics.Nuclear physics[ PHYS.HEXP ] Physics [physics]/High Energy Physics - Experiment [hep-ex]0103 physical sciencesultra high energy cosmic rays; cosmic ray experiments; Astronomy and Astrophysicscosmic radiation: UHEHigh Energy PhysicsCiencias ExactasPierre Auger ObservatorySPECTRUMhybridbackgrounddetector: surface010308 nuclear & particles physicsFísicaUltra high energy cosmic raysAstronomy and AstrophysicsASTROFÍSICAULTRA-HIGH ENERGYfluxExperimental High Energy PhysicsHigh Energy Physics::Experimentcosmic ray experimentshadron[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph]Energy (signal processing)
researchProduct

Dis grand-mère, est-ce que tu as des belles dents ?

2022

undernutritionolder adultsalivaaged[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP.GEG] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyfoodtexture-modified foodoral healthtoothtextureoral comfort
researchProduct

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

2020

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

unstable anginaMyocardial ischaemia[SDV]Life Sciences [q-bio]Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]dual antithrombotic therapyGuidelineheparin030204 cardiovascular system & hematologyPlatelet inhibitionantiplatelet0302 clinical medicineST segmentMedicinedabigatranMyocardial infarctionguidelinesglycoprotein iib/iiia inhibitorsanticoagulationNon-ST Elevated Myocardial InfarctionrivaroxabanComputingMilieux_MISCELLANEOUSreproductive and urinary physiologydiabetesbleedingsbivalirudinatherothrombosiDisease ManagementangioplastyGuidelines • acute cardiac care • acute coronary syndrome • angioplasty • anticoagulation • antiplatelet • apixaban • aspirin • atherothrombosis • betablockers • bleedings • bivalirudin • bypass surgery • cangrelor • chest pain unit • clopidogrel • dabigatran • diabetes • dual antithrombotic therapy • early invasive strategy • edoxaban • enoxaparin • European Society of Cardiology • fondaparinux • glycoprotein IIb/ IIIa inhibitors • heparin • high-sensitivity troponin • minoca • myocardial ischaemia • myocardial infarction • nitrates • non-ST-elevation myocardial infarction • platelet inhibition • prasugrel • recommendations • revascularization • rhythm monitoring • rivaroxaban • stent • ticagrelor • triple therapy • unstable anginaenoxaparinGeneral MedicineClopidogrel3. Good healthearly invasive strategymyocardial infarctiontriple therapy030220 oncology & carcinogenesisHigh sensitivity troponinembryonic structuresCardiologyPlatelet aggregation inhibitorrevascularizationbiological phenomena cell phenomena and immunityCardiology and Cardiovascular MedicineTicagrelormedicine.drugHumanrecommendationAcute coronary syndromemedicine.medical_specialtyaspiringlycoprotein IIb/IIIa inhibitornon-ST-elevation myocardial infarctionapixabanrhythm monitoringEuropean Society of Cardiologyticagrelor03 medical and health sciencesnitrateatherothrombosisbetablockersInternal medicineacute cardiac careminocachest pain unitDiseases of the circulatory (Cardiovascular) systemHumansIn patientAcute Coronary SyndromeclopidogrelUnstable anginaurogenital systemnitratesbusiness.industryfondaparinuxbetablockerArrhythmias Cardiac030229 sport sciencesbleedingmedicine.diseasemyocardial ischaemiaplatelet inhibitionprasugreldiabeteGlycoprotein IIb/IIIa inhibitorsRC666-701bypass surgerySettore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLARErecommendationsedoxabanhigh-sensitivity troponinstentbusinessPlatelet Aggregation Inhibitorscangrelor
researchProduct

Real-world experience with obeticholic acid in patients with primary biliary cholangitis

2021

Background & aims Obeticholic acid (OCA) is the second-line treatment approved for patients with primary biliary cholangitis (PBC) and an inadequate response or intolerance to ursodeoxycholic acid. We aimed to evaluate the effectiveness and safety of OCA under real-world conditions. Methods Patients were recruited into the Italian PBC Registry, a multicentre, observational cohort study that monitors patients with PBC at national level. The primary endpoint was the biochemical response according to Poise criteria; the secondary endpoint was the biochemical response according to normal range criteria, defined as normal levels of bilirubin, alkaline phosphatase (ALP), and alanine aminotransfer…

upper limit of normalCirrhosisALTAMAAutoimmunityantinuclear antibodiesULNPBCGastroenterologyUDCASettore MED/12ULN upper limit of normalobeticholic acidaRR adjusted risk ratio.CRFs case record formAST aspartate transferaseClinical endpointGGT gamma-glutamyl transferaseQCprimary biliary cholangitisGastroenterologyUrsodeoxycholic acidANATCCCirrhosisCholestasiTIPSTreatment Completer CohortANA antinuclear antibodiemedicine.medical_specialtyRRUDCA ursodeoxycholic acidTIPS transjugular intrahepatic portosystemic shuntOCACirrhosiALP alkaline phosphataseautoimmune hepatitismedicine.diseasedigestive system diseasesDiscontinuationKeywords: AIH autoimmune hepatitiQC quality controlchemistrygamma-glutamyl transferaserandomised controlled trialelectronic data captureantimitochondrial antibodiesaspartate transferaseAutoimmune hepatitischemistry.chemical_compoundAIHCRFsImmunology and Allergyadjusted risk ratioANA antinuclear antibodiesRR risk ratioOverall cohortALT alanine transferaseAMA antimitochondrial antibodieCholestasisCRFs case record formsObeticholic acidOverlap PBC-AIHursodeoxycholic acidOCA obeticholic acidTolerabilityalkaline phosphataseRCTResearch Articlemedicine.drugcase record formsContext (language use)AMA antimitochondrial antibodiesInternal medicineEDC electronic data capturetransjugular intrahepatic portosystemic shuntInternal MedicinemedicineRCT randomised controlled trialaRR adjusted risk ratioOClcsh:RC799-869quality controlalanine transferaseASTaRRHepatologybusiness.industryAutoimmunity; Cholestasis; Cirrhosis; Overlap PBC-AIHAIH autoimmune hepatitisTCC Treatment Completer CohortPBC primary biliary cholangitiGGTrisk ratioOC Overall cohortALPlcsh:Diseases of the digestive system. GastroenterologyPBC primary biliary cholangitisbusinessEDC
researchProduct

Perhepäivähoito- ja päiväkoti-instituutio varhaiskasvatuksen kunnallisten viranhaltijoiden puheessa

2022

Tutkimuksessa tarkasteltiin perhepäivähoito- ja päiväkoti-instituutioiden tuottamista varhaiskasvatuksesta vastaavien kunnallisten viranhaltijoiden puheessa. Tutkimus tehtiin kymmenessä suomalaisessa kunnassa, ja aineistona käytettiin teemahaastatteluja (N =42). Perhepäivähoito ja päiväkotitoiminta ymmärrettiin diskursiivisen institutionalismin näkökulmasta sosiaalisina käytäntöinä, joiden merkitykset ilmenevät ja muuttuvat varhaiskasvatuksen instituutioiden kielenkäytössä. Aineistoa analysoitiin diskursiivisesti, ja puheesta erotettiin vaihtelevia tapoja puhua perhepäivähoidosta ia päiväkotitoiminnasta. Löydetyissä puhetavoissa perhepäivähoidolle ja päiväkotitoiminnalle tuotettiin erilaise…

varhaiskasvatus perhepäivähoito päiväkodit instituutiot diskurssintutkimusfamily day carepäiväkoditvarhaiskasvatus516 Kasvatustieteetinstituutiotdiskurssintutkimusinstitutionalismiearly childhood education and careperhepäivähoitoviranhaltijatday care centresArtikkeleitainstitutions (social mechanisms)kindergartenjulkiset palvelutdiscourse researchKasvatus
researchProduct